Search

Issue
Title
Authors
Epidermal Growth Factor Receptor as a Target for Anti-Cancer Agent Design
Cao J., Fang H., Wang B., Ma C., Xu W.
Evolving Therapies and FAK Inhibitors for the Treatment of Cancer
Bullard Dunn K., Heffler M., M. Golubovskaya V.
Erlotinib in Glioblastoma - Lost in Translation?
Karpel-Massler G., Andrew Westhoff M., E. Kast R., Rainer Wirtz C., Halatsch M.
Erlotinib and Gefitinib for Elderly Patients with Advanced Non-small-cell Lung Cancer
Passaro A., Alesini D., Pochesci A., Cortesi E.
Nitroimidazoles as Anti-Tumor Agents
Liu K., Zhu H.
In-Gel Protein Phosphatase Assays and Other Useful Methods for the Detection of Protein Phosphatase Activities
Ishida A., Kameshita I.
Uses of Cyclohexan-1,3-diones to Synthesis Xanthenes Derivatives with Anti-proliferative Activity Against Cancer Cell Lines and their Inhibitions Toward Tyrosine Kinases
Mohareb R., Abdo N., Ibrahim M.
An Insight into Purine, Tyrosine and Tryptophan Derived Marine Antineoplastic Alkaloids
Palkar M., Rane R., Thapliyal N., Shaikh M., Alwan W., Jain K., Karunanidhi S., Patel H., Hampannavar G., Karpoormath R.
Targeting the Fibroblast Growth Factor Receptors for the Treatment of Cancer
Lemieux S., Hadden M.
Focal Adhesion Kinase Controls Prostate Cancer Progression Via Intrinsic Kinase and Scaffolding Functions
Figel S., H. Gelman I.
Combination Therapy with Arsenic Trioxide for Hematological Malignancies
Takahashi S.
Screening and in vitro Biological Evaluation of Novel Multiple Tyrosine Kinases Inhibitors as Promising Anticancer Agents
Li X., Ruan P., Jiang G., Zhang W.
The Applications of Targeting Anti-Cancer Agents in Cancer Therapeutics
Sun G., Yang X., Yu Y., Zhao D.
Recombinant Snake Venom Cystatin Inhibits Tumor Angiogenesis in vitro and in vivo Associated with Downregulation of VEGF-A165, Flt-1 and bFGF
Xie Q., Tang N., Wan R., Qi Y., Lin X., Lin J.
Targeting Receptor Tyrosine Kinase Pathways in Hepatocellular Carcinoma
Wen Chong L., Anh Tuan Luu D., Tzen Jong C., Wei Ling Lam I., Huynh H., Wei Jie Ong R., Yi Qing Li P., Shean Lee S., Yang S.
First Approval of Pacritinib as a Selective Janus Associated Kinase-2 Inhibitor for the Treatment of Patients with Myelofibrosis
De S.
Current Molecularly Targeting Therapies in NSCLC and Melanoma
Rajanna S., Rastogi I., Wojdyla L., Furo H., Kulesza A., Lin L., Sheu B., rakes M., Ivanovich M., Puri N.
JAK2 Inhibitors for Myelofibrosis: Why are They Effective in Patients with and Without JAK2V617F Mutation?
P. S. Santos F., Verstovsek S.
TEM8 Targeted Cancer Therapy
E. Frankel A., Carter C., Kuo S., Woo J., Mauldin J., Liu J.
Mouse Induced Glioma-Initiating Cell Models and Therapeutic Targets
Kondo T.
Novel 5-bromoindole-2-carboxylic Acid Derivatives as EGFR Inhibitors: Synthesis, Docking Study, and Structure Activity Relationship
Hassan O., Kubba A., Tahtamouni L.
Design, Synthesis and Biological Evaluation of Quinoxalin-2(1H)-one Derivatives as EGFR Tyrosine Kinase Inhibitors
Qin X., Han X., Hu L., Li Z., Geng Z., Wang Z., Zeng C., Xiao X.
Rational Drug Design for Identifying Novel Multi-target Inhibitors for Hepatocellular Carcinoma
Temirak A., Abdulla M., Elhefnawi M.
Metal-Based Inhibitors of Protein Tyrosine Phosphatases
Lu L., Zhu M.
Anaplastic Lymphoma Kinase as a Therapeutic Target in Anaplastic Large Cell Lymphoma, Non-Small Cell Lung Cancer and Neuroblastoma
Cheng M., R. Ott G.
Recent Developments on Thiourea Based Anticancer Chemotherapeutics
Kumar V., Chimni S.
New Targeted Therapies for Anaplastic Thyroid Cancer
Antonelli A., Fallahi P., Ulisse S., Martina Ferrari S., Minuto M., Saraceno G., Santini F., Mazzi V., D'Armiento M., Miccoli P.
Tumor-Derived Extracellular Fragments of Receptor Protein Tyrosine Phosphatases (RPTPs) as Cancer Molecular Diagnostic Tools
E.L. Craig S., M. Brady-Kalnay S.
Recent Advances and Future Directions in the Management of Metastatic Renal Cell Carcinoma
Ansari J., Glaholm J., McMenemin R., James N., Hussain S.
EGFRIndb: Epidermal Growth Factor Receptor Inhibitor Database
Yadav I., Singh H., Khan M., Chaudhury A., Raghava G., Agarwal S.
Impact of Oncogenic Protein Tyrosine Phosphatases in Cancer
Hardy S., G. Julien S., L. Tremblay M.
Dual-Specificity MAP Kinase Phosphatases as Targets of Cancer Treatment
Nunes-Xavier C., Roma-Mateo C., Rios P., Tarrega C., Cejudo-Marin R., Tabernero L., Pulido R.
Physiological Modulation Approaches to Improve Cancer Chemotherapy : A Review
Kumar R., Kaur M., Silakari O.
SHP-1 in Cell-Cycle Regulation
Lopez-Ruiz P., Rodriguez-Ubreva J., Ernesto Cariaga A., Alicia Cortes M., Colas B.
Discovery of Small Molecule c-Met Inhibitors: Evolution and Profiles of Clinical Candidates
Underiner T., Herbertz T., Miknyoczki S.
1 - 35 of 35 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"